Post transplant lymphoproliferative disorder epidemiology and demographics: Difference between revisions
(Created page with "__NOTOC__ {{Post transplant lymphoproliferative disorder}} {{CMG}} Please help WikiDoc by adding more content here. It's easy! Click here to l...") |
No edit summary |
||
| Line 11: | Line 11: | ||
==References== | ==References== | ||
{{Reflist|2}} | |||
[[Category:Needs Content]] | [[Category:Needs Content]] | ||
[[Category:Transplantation medicine]] | [[Category:Transplantation medicine]] | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
Latest revision as of 18:46, 27 August 2015
|
Post transplant lymphoproliferative disorder Microchapters |
|
Differentiating Post transplant lymphoproliferative disorder from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Post transplant lymphoproliferative disorder epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Post transplant lymphoproliferative disorder epidemiology and demographics |
|
FDA on Post transplant lymphoproliferative disorder epidemiology and demographics |
|
CDC on Post transplant lymphoproliferative disorder epidemiology and demographics |
|
Post transplant lymphoproliferative disorder epidemiology and demographics in the news |
|
Blogs on Post transplant lymphoproliferative disorder epidemiology and demographics |
|
Directions to Hospitals Treating Post transplant lymphoproliferative disorder |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
Incidence and Prevalence
It is an uncommon condition occurring in 0.2% of patients within one year of transplant, with an annual incidence of 0.04% thereafter. The risk of developing the disease is higher in children and recipients of heart transplants.